Standards; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites;
應(yīng)用:
Methyl Caffeoate is a potential therapeutic agents that inhibits the production of inflammatory markers, IL-6 and nitric oxide from IL-1β-treated lung epithelial cells and lipopolysaccharide (LPS)-treated alveolar macrophages. A caffeic acid derivative found in the Asteraceae.
?您的位置：
